The association of multiple anti-hypertensive medication classes with Alzheimer’s disease incidence across sex, race, and ethnicity

BACKGROUND: Antihypertensive treatments have been shown to reduce the risk of Alzheimer’s disease (AD). The renin-angiotensin system (RAS) has been implicated in AD, and thus RAS-acting AHTs (angiotensin converting enzyme inhibitors (ACEIs), and angiotensin-II receptor blockers (ARBs)) may offer dif...

Descripción completa

Detalles Bibliográficos
Autores principales: Barthold, Douglas, Joyce, Geoffrey, Wharton, Whitney, Kehoe, Patrick, Zissimopoulos, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211717/
https://www.ncbi.nlm.nih.gov/pubmed/30383807
http://dx.doi.org/10.1371/journal.pone.0206705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211717/
https://www.ncbi.nlm.nih.gov/pubmed/30383807
http://dx.doi.org/10.1371/journal.pone.0206705

Ejemplares similares